Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report

被引：13
|
作者：
Torcuator, Roy [1 ]
Zuniga, Richard [1 ]
Loutfi, Randa [2 ]
Mikkelsen, Tom [1 ,3 ]
机构：
[1] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurosurg, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Med Oncol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Hermelin Brain Tumor Ctr, Dept Neurol, Detroit, MI 48202 USA
来源：
JOURNAL OF NEURO-ONCOLOGY | 2009年 / 93卷 / 03期
关键词：
Brainstem; Glioma; Diffuse chemotherapy; Bevacizumab; Irinotecan; CHILDREN; CHEMOTHERAPY; RADIOTHERAPY; TRIAL;
D O I：
10.1007/s11060-008-9782-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Diffuse brainstem glioma carries a dismal prognosis. The current cornerstone of treatment is radiation therapy. Chemotherapy appears to be ineffective and the role of this treatment in the recurrent or progressive setting is not known. Bevacizumab and irinotecan have been reported to have shown radiographic response and improvement in progression-free survival among patients with malignant supratentorial gliomas. In this paper, we report our experience in an adult patient with progressive diffuse brainstem glioma treated with bevacizumab and irinotecan.
引用
收藏
页码：409 / 412
页数：4
相关论文
共 50 条
  • [41] Diffuse, non-traumatic, non-aneurysmal subarachnoid haemorrhage during bevacizumab treatment of high grade glioma: case report and review of the literature
    Dissanayake, Arosha S.
    Ramakonar, Hari H.
    Lind, Christopher R. P.
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2015, 2 (02): : 65 - 68
  • [42] Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature
    Nguyen, Timothy K.
    Perry, James
    Sundaram, Arun N. E.
    Detsky, Jay
    Maralani, Pejman J.
    Calabrese, Eirena
    Das, Sunit
    Sahgal, Arjun
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (03) : 475 - 481
  • [43] Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option
    Flieger, Maya
    Ganswindt, Ute
    Schwarz, Silke Birgit
    Kreth, Friedrich-Wilhelm
    Tonn, Joerg-Christian
    la Fougere, Christian
    Ertl, Lorenz
    Linn, Jennifer
    Herrlinger, Ulrich
    Belka, Claus
    Niyazi, Maximilian
    JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (02) : 337 - 345
  • [44] Diffuse brainstem glioma: prognostic factors Clinical article
    Dellaretti, Marcos
    Reyns, Nicolas
    Touzet, Gustavo
    Dubois, Francois
    Gusmao, Sebastiao
    Barbosa Pereira, Julio Leonardo
    Blond, Serge
    JOURNAL OF NEUROSURGERY, 2012, 117 (05) : 810 - 814
  • [45] Efficacy and safety of bevacizumab in progressive pediatric low-grade glioma: a systematic review and meta-analysis of outcome rates
    Lu, Victor M.
    Welby, John P.
    Nesvick, Cody L.
    Daniels, David J.
    NEURO-ONCOLOGY PRACTICE, 2020, 7 (04) : 359 - 368
  • [46] Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study
    Bennebroek, Carlien A. M.
    van Zwol, Judith
    Porro, Giorgio L.
    Oostenbrink, Rianne
    Dittrich, Anne T. M.
    Groot, Annabel L. W.
    Pott, Jan W.
    Janssen, Etienne J. M.
    Bauer, Noel J.
    van Genderen, Maria M.
    Saeed, Peerooz
    Lequin, Maarten H.
    de Graaf, Pim
    Schouten-van Meeteren, Antoinette Y. N.
    CANCERS, 2022, 14 (24)
  • [47] Vincristine, Irinotecan, and Bevacizumab in Relapsed Wilms Tumor With Diffuse Anaplasia
    Schiavetti, Amalia
    Varrasso, Giulia
    Collini, Paola
    Clerico, Anna
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2018, 40 (04) : 331 - 333
  • [48] The role of brainstem biopsy and targeted therapies in pediatric diffuse midline glioma/diffuse intrinsic pontine glioma
    Sheikh, Shehryar R.
    Recinos, Violette M. R.
    Thompson, Eric M.
    Mangum, Ross
    Wright-Nadkarni, Mariah
    Gampel, Bradley
    Patel, Neha J.
    Natl Pediat Canc Fdn NPCF Cent Nervous Syst Task Force
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [49] A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma
    Su, Jack Meng-Fen
    Murray, Jeffrey C.
    McNall-Knapp, Rene Y.
    Bowers, Daniel C.
    Shah, Shafqat
    Adesina, Adekunle M.
    Paulino, Arnold C.
    Jo, Eunji
    Mo, Qianxing
    Baxter, Patricia A.
    Blaney, Susan M.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (06)
  • [50] Bevacizumab for the treatment of high-grade glioma
    Khasraw, Mustafa
    Simeonovic, Marcelle
    Grommes, Christian
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (08) : 1101 - 1111
12345